What Has Been The Evolution of the Vascular Embolization Market in Recent Years?
The vascular embolization market has seen considerable growth due to a variety of factors.
•In recent times, the vascular embolization market has experienced robust growth. The market is projected to expand from $3.15 billion in 2024 to $3.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.0%.
The increase during the historical time frame can be ascribed to a growing incidence of vascular illnesses, heightened demand for non-coiling apparatuses, a surge in the usage of clotting agents, and elevated knowledge about sophisticated treatment alternatives.
What Is the Forecasted Market Size and Growth Rate for The Vascular Embolization Market?
The vascular embolization market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the size of the vascular embolization market is projected to see substantial growth. It is estimated to increase at a compound annual growth rate (CAGR) of 9.6%,
reaching $4.91 billion by 2029. The surge in the forecast time period can be linked to increasing chronic disease cases, rising investments in research and development activities, a growing inclination towards minimally invasive procedures, geographical expansion and improved healthcare access, along with increasing disposable incomes. Key trends during this forecast period will include developments in technology, multiple strategic partnerships, and the creation of innovative vascular embolization devices.
Which Factors Are Boosting Growth In The Vascular Embolization Market?
The forecasted expansion of the vascular embolization market is primarily driven by the surge in vascular disease cases. These diseases, characterized by disorders affecting the arteries and veins, impede blood flow, subsequently leading to a range of conditions like peripheral vascular disease, abdominal aortic aneurysm, deep vein thrombosis, atherosclerosis, chronic venous insufficiency, and peripheral artery diseases, among others. Vascular embolization plays a vital role in the treatment of vascular disorders by obstructing blood vessels to cease bleeding, mend aneurysms, and enhance blood supply in veins. For example, HMP Communications LLC, a US-centric patient education resource, reported in April 2023 that the worldwide occurrence of peripheral artery diseases (PAD) was 21 million in 2020 and is projected to hit 23.8 million by 2030. Therefore, the ascending prevalence of vascular diseases is spurring the vascular embolization market's expansion.
What Key Areas Define The Segmentation Of The Global Vascular Embolization Market?
The vascular embolization market covered in this report is segmented –
1) By Product: Embolic Agents, Embolization Devices
2) By Embolization Technique: Coiling Devices, Non-Coiling Devices
3) By Application: Peripheral Vascular Diseases, Oncology, Urology, Neurology, Other Applications
4) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers
Subsegments:
1) By Embolic Agents: Particle Embolic Agents, Liquid Embolic Agents, Coil Embolic Agents, Gelatin Sponge Embolic Agents
2) By Embolization Devices: Balloon Occlusion Devices, Catheters, Thrombin Injection Systems
Pre-Book The Vascular Embolization Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Vascular Embolization Market?
The emergence of advanced technologies is a prominent trend that's making waves in the vascular embolization market. To maintain their standing in the industry, leading companies in the market are innovating and developing revolutionary solutions. For example, in June 2022, India Medtronic Private Limited, a subsidiary of US-based Medtronic PLC, rolled out Pipeline Vantage; a flex embolization device engineered to address brain aneurysms. With its new shield technology, Pipeline Vantage is a game-changing flow diverter featuring superior delivery design traits. It's these specific characteristics of the device that ease and enhance reliability in transporting, deploying, and treating brain and intracranial aneurysms. Additionally, it offers a scaffold that stimulates cell growth in the interior lining of the target blood vessels.
Who Are the Key Players in the Vascular Embolization Market?
Major companies operating in the vascular embolization market include:
• Abbott Laboratories
• Medtronic Plc.
• Merck Group
• Stryker Corporation
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Kaneka Corporation
• Terumo Corporation
• W. L. Gore & Associates Inc.
• Teleflex Inc.
• Cook Group Incorporated
• Merit Medical Systems Inc.
• Penumbra Inc.
• MicroPort Scientific Corporation
• MicroVention Inc.
• Medikit Co Ltd.
• Silk Road Medical Inc.
• Galt Medical Corporation
• Neuravi Ltd.
• Phenox GmbH
• Spartan Micro Inc.
• EndoShape Inc.
• Shape Memory Medical Inc.
• Balt Group
• Vascular Solutions Inc.
What Is The Most Dominant Region In The Vascular Embolization Market?
North America was the largest region in the vascular embolization market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular embolization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
